Due to the need for more time to update the documents, Wisdom Education International Holdings Co. (WRD.US) postponed its IPO in the United States.
Boyun Education Inc. (WRD.US) has postponed its initial public offering (IPO) on NASDAQ to allow more time to submit documents to regulatory authorities.
According to reports, Chinese self-driving technology company WeRide (WRD.US) has postponed its initial public offering (IPO) plan on Nasdaq to allow more time to submit documents to regulatory agencies. In response, WeRide stated that the time required to update the trading documents is longer than expected, and they are actively working on all the necessary documents for the transaction.
It was reported that WeRide submitted its IPO application earlier this month, with a valuation of up to $5 billion. WeRide plans to issue 6.5 million shares at a price range of $15.50 to $18.50 per share, raising $109.7 million.
It is known that WeRide has completed 10 rounds of financing, with investors including He Xiaopeng, Guangzhou Automobile Group, NVIDIA Corporation, Bosch, IDG Capital, Qiming Venture Partners, and Foundation Capital. The total amount of public financing exceeds $1.09 billion, with the final D+ round of financing completed in 2022, valuing the company at $5.1 billion.
In addition, according to regulations of Chinese regulatory agencies, WeRide is required to list within one year after obtaining approval for its IPO to the US, which means by August 25th of this year.
Related Articles

HK Stock Market Move | XUANZHUBIO-B (02575) rose over 7% in early trading; the company issued a clarification announcement, disclosing that it is in negotiations regarding a potential acquisition.

HK Stock Market Move | Jiangsu Hengrui Pharmaceuticals (01276) rose nearly 4% as the company conducted its first A-share buyback; institutions are bullish that the non-oncology segment will continue to contribute incremental product-side growth.

Morgan Stanley: Gives KB LAMINATES (01888) an "Overweight" rating with a target price of HK$75
HK Stock Market Move | XUANZHUBIO-B (02575) rose over 7% in early trading; the company issued a clarification announcement, disclosing that it is in negotiations regarding a potential acquisition.

HK Stock Market Move | Jiangsu Hengrui Pharmaceuticals (01276) rose nearly 4% as the company conducted its first A-share buyback; institutions are bullish that the non-oncology segment will continue to contribute incremental product-side growth.

Morgan Stanley: Gives KB LAMINATES (01888) an "Overweight" rating with a target price of HK$75

RECOMMEND





